Promab Biotechnologies, Inc.
Richmond, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2600 Hilltop Dr c320, Richmond, CA 94806, USA
- Website
- promab.com
- Founded
- 2001
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$15,180 |
| FY2023 | -$45,875 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Promab Biotechnologies (PMB) develops and commercializes recombinant proteins, antibodies, and engineered cell lines through the integration of bioinformatics, molecular biology, protein expression, purification techniques, gene cloning, microbiology, and other areas. It is a minority-owned, Asian-Pacific American-owned, for-profit small business registered to receive awards from the U.S. federal government.
Through federal contract awards, Promab Biotechnologies has provided services such as antibody production, DNA synthesis, and subcloning for baculovirus and yeasts. One contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention was a $16,630.00 firm fixed-price purchase order for antibody production, with a completion date of August 6, 2021. This contract had a small business set-aside designation and was performed in Richmond, California. Another contract from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute was a $49,675.00 purchase order for DNA synthesis and subcloning for baculovirus and yeasts, with a completion date of January 23, 2021.
Through federal grant awards, Promab Biotechnologies has been a sub-awardee for work related to NK and macrophage CAR T cell work. The prime grantee for this sub-award was Sri International. No further details on the specific federal grant program or funding agency were provided.
Quick answers
Is Promab Biotechnologies, Inc. registered in SAM.gov?
Yes. Promab Biotechnologies, Inc.'s SAM.gov registration is active through June 19, 2027.
What is Promab Biotechnologies, Inc.'s CAGE code?
Promab Biotechnologies, Inc.'s CAGE code is 4GC13, and its Unique Entity ID (UEI) is MNDNCKJR4WL9.
What is Promab Biotechnologies, Inc.'s most recent federal award?
Promab Biotechnologies, Inc.'s most recent federal contract award is Antibody production (75D30121P10335), from CDC Pittsburgh, on March 1, 2021.
On GovTribe
See Promab Biotechnologies, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors